Parkside Financial Bank & Trust’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.04K | Buy |
81
+12
| +17% | +$725 | ﹤0.01% | 1772 |
|
|
2026
Q1 | $2.78K | Buy |
69
+16
| +30% | +$598 | ﹤0.01% | 2004 |
|
|
2025
Q4 | $1.84K | Buy |
53
+12
| +29% | +$943 | ﹤0.01% | 2130 |
|
|
2025
Q3 | $3.41K | Sell |
41
-52
| -56% | -$3.76K | ﹤0.01% | 1842 |
|
|
2025
Q2 | $6.83K | Buy |
93
+31
| +50% | +$2.25K | ﹤0.01% | 1610 |
|
|
2025
Q1 | $7.08K | Buy |
62
+40
| +182% | +$2.44K | ﹤0.01% | 1527 |
|
|
2024
Q4 | $1.11K | Hold |
22
| – | – | ﹤0.01% | 1719 |
|
|
2024
Q3 | $1.02K | Hold |
22
| – | – | ﹤0.01% | 1704 |
|
|
2024
Q2 | $715 | Hold |
22
| – | – | ﹤0.01% | 1707 |
|
|
2024
Q1 | $555 | Sell |
22
-2
| -8% | -$47 | ﹤0.01% | 1730 |
|
|
2023
Q4 | $780 | Sell |
24
-332
| -93% | -$9.12K | ﹤0.01% | 1664 |
|
|
2023
Q3 | $9.7K | Hold |
356
| – | – | ﹤0.01% | 1132 |
|
|
2023
Q2 | $7.92K | Hold |
356
| – | – | ﹤0.01% | 1201 |
|
|
2023
Q1 | $7.71K | Buy |
356
+33
| +10% | +$723 | ﹤0.01% | 1195 |
|
|
2022
Q4 | $6.56K | Hold |
323
| – | – | ﹤0.01% | 1211 |
|
|
2022
Q3 | $8K | Hold |
323
| – | – | ﹤0.01% | 1049 |
|
|
2022
Q2 | $8K | Buy |
323
+24
| +8% | +$523 | ﹤0.01% | 1059 |
|
|
2022
Q1 | $7K | Sell |
299
-108
| -27% | -$2.3K | ﹤0.01% | 1142 |
|
|
2021
Q4 | $8K | Buy |
407
+46
| +13% | +$933 | ﹤0.01% | 1094 |
|
|
2021
Q3 | $7K | Buy |
361
+4
| +1% | +$84 | ﹤0.01% | 1072 |
|
|
2021
Q2 | $8K | Buy |
357
+26
| +8% | +$579 | ﹤0.01% | 1029 |
|
|
2021
Q1 | $8K | Hold |
331
| – | – | ﹤0.01% | 1002 |
|
|
2020
Q4 | $9K | Buy |
331
+215
| +185% | +$4.53K | ﹤0.01% | 900 |
|
|
2020
Q3 | $2K | Buy |
116
+5
| +5% | +$80 | ﹤0.01% | 1139 |
|
|
2020
Q2 | $2K | Hold |
111
| – | – | ﹤0.01% | 1145 |
|
|
2020
Q1 | $1K | Sell |
111
-25
| -18% | -$309 | ﹤0.01% | 1230 |
|
|
2019
Q4 | $2K | Hold |
136
| – | – | ﹤0.01% | 1152 |
|
|
2019
Q3 | $2K | Buy |
+136
| New | +$1.67K | ﹤0.01% | 1132 |
|
|
2019
Q2 | – | Sell |
-137
| Closed | -$2K | – | 1595 |
|
|
2019
Q1 | $2K | Buy |
137
+84
| +158% | +$1.04K | ﹤0.01% | 1144 |
|
|
2018
Q4 | $1K | Sell |
53
-8
| -13% | -$106 | ﹤0.01% | 1182 |
|
|
2018
Q3 | $1K | Buy |
61
+9
| +17% | +$126 | ﹤0.01% | 1233 |
|
|
2018
Q2 | $1K | Sell |
52
-16
| -24% | -$278 | ﹤0.01% | 1205 |
|
|
2018
Q1 | $1K | Buy |
+68
| New | +$1.26K | ﹤0.01% | 1150 |
|
Other funds holding CORT
ISL
PA
Parkside Financial Bank & Trust's CORT Position: Q2 2026 in Review
Parkside Financial Bank & Trust increased its Corcept Therapeutics (CORT) stake by 17% in Q2 2026, buying an estimated $725 and bringing the position to 81 shares worth $7.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1772.
Parkside Financial Bank & Trust first reported a position in CORT in Q1 2018 and has held it in 33 quarters since. The position peaked at $9.7K in Q3 2023. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Parkside Financial Bank & Trust held 81 shares of Corcept Therapeutics worth $7.04K as of Q2 2026.
- Parkside Financial Bank & Trust bought 12 Corcept Therapeutics shares in Q2 2026, an estimated $725.
- Corcept Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1772 holding.
- Parkside Financial Bank & Trust first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 33 quarters since.
- Parkside Financial Bank & Trust's Corcept Therapeutics position peaked at $9.7K in Q3 2023.
- 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.